IN THE NEWS

Ritedose news
and updates.

Learn more about Ritedose and the community.
Press releases, news stories, partnerships, community events, and more.

Media Inquiries

Schedule your interview and learn more about the Ritedose Company.

Alex Keown

media@ritedose.com

23October2026

Why Pharmaceutical Manufacturing Flexibility Starts Requires More than Capacity

Pharmaceutical manufacturing flexibility is about more than capacity. It means having the infrastructure, validated processes, people and available production capacity to respond when demand changes—without compromising quality or supply.

19October2026

Ritedose Partners with Newberry College to Launch Leadership Development Program

Organizational development and pharmaceutical leadership certificate is designed to strengthen organizational leadership at Ritedose

13October2026

Overcoming Manufacturing Challenges for Ophthalmic Drugs

Preservatives like benzalkonium chloride can irritate the eye, especially with long-term use. Removing them makes manufacturing even more important. Learn how sterile Blow-Fill-Seal (BFS) technology and single-unit packaging help ophthalmic drug developers maintain microbial control without relying on preservatives.

7October2026

Ritedose Opens Advanced Laboratory and Expands Analytical Capabilities to Accelerate Pharmaceutical Innovation—Positioning the Company as a Preferred Partner for Drug Development and Manufacturing

– Triples laboratory footprint with the $17 million investment. – Features new leachables and extractables testing capabilities. – Allows for seamless development and manufacturing experience while supporting pharmaceutical products throughout entire lifecycle. – Creates an integrated laboratory infrastructure coupled with…

5October2026

What Ophthalmic Drug Developers Need in a CDMO

Clinical success is only the beginning. For ophthalmic drug developers, the right CDMO can help turn clinical progress into a scalable, sterile, high-quality manufacturing strategy built for commercialization.

24September2026

Ritedose Positioned to Support Hospitals with Reliable and Quality Albuterol Inhalation Solution, USP 0.5% (Albuterol Concentrate) Supply

– Ritedose expands albuterol inhalation solution production and strengthens its role as a trusted source for inhaled solutions. – The Company ramped up multiple albuterol inhalation solution strengths during national shortage, reinforcing its role as a trusted source for inhaled…

Albuterol inhalation solution supply and manufacturing at Ritedose

16September2026

How a Culture of Learning Improves Pharmaceutical Manufacturing Quality

Discover how lifelong learning helps Ritedose strengthen manufacturing quality, develop leaders and improve outcomes for patients.

Lifelong learning in pharmaceutical manufacturing at Ritedose

10September2026

Ritedose Appoints Carolyn Berg as New Vice President of Strategic Growth

The role will focus on identifying new opportunities and strengthening existing customer relationships to accelerate Ritedose’s continued growth.

Carolyn Berg, Vice President of Strategic Growth at Ritedose

2September2026

One Size No Longer Fits All in Pharmaceutical Manufacturing

Specialized CDMOs combine precision, agility and scale to meet the evolving needs of complex pharmaceutical manufacturing. This is production on purpose.

Specialized CDMO pharmaceutical manufacturing at Ritedose

27August2026

Resilience Is a Commitment to Learning

Discover how learning, quality and continuous improvement help Ritedose build resilience and strengthen pharmaceutical manufacturing.

Resilience in pharmaceutical manufacturing through learning and continuous improvement at Ritedose

12August2026

Patient Behavior Drives a Better Design

Learn how patient behavior can inform pharmaceutical product design, packaging and delivery to create safer, more intuitive therapies.

Patient Behavior in pharmaceutical manufacturing at Ritedose

6August2026

Hidden Contamination: What Preservative-Free Ophthalmic Patients Need to Know

Learn how Blow-Fill-Seal manufacturing supports ophthalmic sterility and why proper handling of single-use ophthalmic products is essential to preventing microbial contamination.

Ophthalmic sterility supported through Blow-Fill-Seal manufacturing at Ritedose

29July2026

Why Reclosing a Single-Use Ophthalmic Vial Doesn’t Restore Sterility

A vial may look protected after being closed again, but sterility cannot be restored once a single-use ophthalmic vial has been opened.

11June2026

Ritedose Commits to National “Hope Alliance” Campaign to Support Uninsured Patients

The leader in unit dose sterile medications pledges to the Dispensary of Hope a long-term supply of critical respiratory medications to stabilize care for vulnerable populations.

Dispensary of Hope patient story highlights Ritedose support for uninsured patients

22May2026

Purpose at Scale: What “Driven by Purpose” Looks Like in Pharmaceutical Manufacturing

Ritedose explores how purpose-driven pharmaceutical manufacturing strengthens quality, innovation and patient-centered care.

Ritedose pharmaceutical manufacturing team focused on purpose-driven innovation

12May2026

Eyedrop recall underscores need for quality focus

An FDA eye drop recall involving sterility concerns highlights the critical role of cGMP compliance, aseptic processing, and Blow-Fill-Seal technology in safe ophthalmic drug manufacturing.

Close-up of human eye with text overlay that reads, "Paramount safety: proven sterility."

7May2026

Why Pharmaceutical Resilience Is Critical in Drug Manufacturing

Pharmaceutical resilience is essential to strengthening the U.S. drug supply chain against shortages, global dependencies, and emerging risks.

Pharmaceutical resilience in U.S. drug manufacturing and supply chain

28April2026

Ritedose Reaches “1,000 Hours of Purpose”

Employee-led initiative deepens Ritedose’s commitment to Midlands nonprofits and the communities they serve.

Ritedose community service volunteers supporting Midlands nonprofits

23April2026

Ritedose, University of South Carolina Welcome Top European Business Students for Immersive Learning about Advanced Manufacturing

– Collaboration showcases the Ritedose Center of Excellence as a global hub for advanced manufacturing education. – The Center of Excellence serves as a cornerstone of Ritedose’s broader commitment to workforce development and industry leadership.

ESCP Business School students visiting Ritedose Manufacturing Center of Excellence at University of South Carolina partnership event

10April2026

What Does it Mean to be a Manufacturer of Choice?

Ritedose explains how quality, reliability, and Blow-Fill-Seal (BFS) expertise define what it means to be a true manufacturer of choice in pharmaceutical manufacturing.

Manufacturer of Choice pharmaceutical manufacturing at Ritedose

FEATURED NEWS

23rd October 2026

RECEIVE THE LATEST NEWS

Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.

Ritedose news
and updates.

Media Inquiries

Alex Keown

media@ritedose.com

Why Pharmaceutical Manufacturing Flexibility Starts Requires More than Capacity

Ritedose Partners with Newberry College to Launch Leadership Development Program

Overcoming Manufacturing Challenges for Ophthalmic Drugs

Ritedose Opens Advanced Laboratory and Expands Analytical Capabilities to Accelerate Pharmaceutical Innovation—Positioning the Company as a Preferred Partner for Drug Development and Manufacturing

What Ophthalmic Drug Developers Need in a CDMO

Ritedose Positioned to Support Hospitals with Reliable and Quality Albuterol Inhalation Solution, USP 0.5% (Albuterol Concentrate) Supply

How a Culture of Learning Improves Pharmaceutical Manufacturing Quality

Ritedose Appoints Carolyn Berg as New Vice President of Strategic Growth

One Size No Longer Fits All in Pharmaceutical Manufacturing

Resilience Is a Commitment to Learning

Patient Behavior Drives a Better Design

Hidden Contamination: What Preservative-Free Ophthalmic Patients Need to Know

Why Reclosing a Single-Use Ophthalmic Vial Doesn’t Restore Sterility

Ritedose Commits to National “Hope Alliance” Campaign to Support Uninsured Patients

Purpose at Scale: What “Driven by Purpose” Looks Like in Pharmaceutical Manufacturing

Eyedrop recall underscores need for quality focus

Why Pharmaceutical Resilience Is Critical in Drug Manufacturing

Ritedose Reaches “1,000 Hours of Purpose”

Ritedose, University of South Carolina Welcome Top European Business Students for Immersive Learning about Advanced Manufacturing

What Does it Mean to be a Manufacturer of Choice?

FEATURED NEWS

Why Pharmaceutical Manufacturing Flexibility Starts Requires More than Capacity

Overcoming Manufacturing Challenges for Ophthalmic Drugs

What Ophthalmic Drug Developers Need in a CDMO

How a Culture of Learning Improves Pharmaceutical Manufacturing Quality

One Size No Longer Fits All in Pharmaceutical Manufacturing

Resilience Is a Commitment to Learning

Patient Behavior Drives a Better Design

Hidden Contamination: What Preservative-Free Ophthalmic Patients Need to Know

Why Reclosing a Single-Use Ophthalmic Vial Doesn’t Restore Sterility

Purpose at Scale: What “Driven by Purpose” Looks Like in Pharmaceutical Manufacturing

RECEIVE THE LATEST NEWS

TAGS CLOUD

Quick Links

Receive the latest news.

Ritedose news and updates.

Media Inquiries

Alex Keown

FEATURED NEWS

RECEIVE THE LATEST NEWS

TAGS CLOUD

Tags

Quick Links

Receive the latest news.

Ritedose news
and updates.